NYSE · SIC 8731
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $11.4B | $13.9B | $14.4B | $15.0B | $15.4B | $16.3B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $731.0M | $1.4B | $1.8B | $2.0B | $2.2B | $2.2B |
| Net income | $279.0M | $966.0M | $1.1B | $1.4B | $1.4B | $1.4B |
| Diluted EPS | $1.43 | $4.95 | $5.72 | $7.29 | $7.49 | $7.84 |
| Operating cash flow | $2.0B | $2.9B | $2.3B | $2.1B | $2.7B | $2.7B |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 6.4% | 10.0% | 12.5% | 13.2% | 14.3% | 13.4% |
| Net margin | 2.5% | 7.0% | 7.6% | 9.1% | 8.9% | 8.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8B | $3.9B | $4.0B | $3.8B | $4.0B | $4.1B | $4.4B | $4.2B |
| Gross profit | $863.0M | $915.0M | — | — | — | — | — | — |
| Operating income | $520.0M | $550.0M | $626.0M | $496.0M | $506.0M | $553.0M | $627.0M | $514.0M |
| Net income | $363.0M | $285.0M | $437.0M | $249.0M | $266.0M | $331.0M | $514.0M | $274.0M |
| Diluted EPS | $1.97 | $1.55 | $2.41 | $1.40 | $1.54 | $1.93 | $2.97 | $1.61 |
| Operating cash flow | $588.0M | $721.0M | $885.0M | $568.0M | $443.0M | $908.0M | $735.0M | $618.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 22.6% | 23.5% | — | — | — | — | — | — |
| Operating margin | 13.6% | 14.1% | 15.8% | 13.0% | 12.6% | 13.5% | 14.4% | 12.4% |
| Net margin | 9.5% | 7.3% | 11.0% | 6.5% | 6.6% | 8.1% | 11.8% | 6.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-23 | LEONARD JOHN M | Award | 1,571 | $0.00 | $0.00 | filing |
| 2026-04-23 | GOGGINS COLLEEN A | Award | 1,571 | $0.00 | $0.00 | filing |
| 2026-04-23 | DANHAKL JOHN G | Award | 1,571 | $0.00 | $0.00 | filing |
| 2026-04-23 | Burt Carol | Award | 1,571 | $0.00 | $0.00 | filing |
| 2026-02-13 | Fedock Michael J.· See Remarks | Tax withholding | 123 | $166.94 | $20,533.62 | filing |
| 2026-02-13 | Haas Bernd· See Remarks | Tax withholding | 20 | $166.94 | $3,338.80 | filing |
| 2026-02-08 | BOUSBIB ARI· See Remarks | Tax withholding | 28,399 | $187.49 | $5.3M | filing |
| 2026-02-08 | Bruehlman Ronald E· See Remarks | Tax withholding | 6,801 | $187.49 | $1.3M | filing |
| 2026-02-08 | Grenfell Alistair· See Remarks | Tax withholding | 5,545 | $187.49 | $1.0M | filing |
| 2026-02-08 | Fedock Michael J.· See Remarks | Tax withholding | 2,420 | $187.49 | $453,725.80 | filing |
| 2026-02-08 | Patel Bhavik· See Remarks | Tax withholding | 1,920 | $187.49 | $359,980.80 | filing |
| 2026-02-08 | Sherbet Eric· See Remarks | Tax withholding | 1,915 | $187.49 | $359,043.35 | filing |
| 2026-02-08 | Berkshire James G.· See Remarks | Tax withholding | 1,280 | $187.49 | $239,987.20 | filing |
| 2026-02-08 | STAUB W RICHARD· See Remarks | Tax withholding | 806 | $187.49 | $151,116.94 | filing |
| 2026-02-08 | Haas Bernd· See Remarks | Tax withholding | 440 | $187.49 | $82,495.60 | filing |
| 2026-02-08 | Cherofsky Keriann· See Remarks | Tax withholding | 415 | $187.49 | $77,808.35 | filing |
| 2026-02-08 | BOUSBIB ARI· See Remarks | Award | 57,177 | $0.00 | $0.00 | filing |
| 2026-02-08 | Haas Bernd· See Remarks | Award | 8,265 | $0.00 | $0.00 | filing |
| 2026-02-08 | Grenfell Alistair· See Remarks | Award | 11,795 | $0.00 | $0.00 | filing |
| 2026-02-08 | Fedock Michael J.· See Remarks | Award | 6,735 | $0.00 | $0.00 | filing |
| 2026-02-08 | Patel Bhavik· See Remarks | Award | 4,083 | $0.00 | $0.00 | filing |
| 2026-02-08 | Sherbet Eric· See Remarks | Award | 6,806 | $0.00 | $0.00 | filing |
| 2026-02-08 | STAUB W RICHARD· See Remarks | Award | 2,722 | $0.00 | $0.00 | filing |
| 2026-02-08 | Cherofsky Keriann· See Remarks | Award | 1,087 | $0.00 | $0.00 | filing |
| 2026-02-08 | Bruehlman Ronald E· See Remarks | Award | 16,335 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.